NAPSA Primary Antibody
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
Purified antibody in PBS with 0.05% sodium azide
4°C; -20°C for long term storage
Figure 1: Western blot analysis using NAPSA mAb against human NAPSA recombinant protein. (Expected MW is 40.9 kDa)
Figure 2: Western blot analysis using NAPSA mAb against HEK293 (1) and NAPSA (AA: 20-158)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3: Western blot analysis using NAPSA mouse mAb against rat liver tissue lysate.
Figure 4: Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using NAPSA mouse mAb with DAB staining.
Figure 5: Immunohistochemical analysis of paraffin-embedded liver cancer tissues using NAPSA mouse mAb with DAB staining.
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
For Research Use Only. Not for use in diagnostic procedures.